scispace - formally typeset
Open AccessJournal ArticleDOI

Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians

Reads0
Chats0
TLDR
In this article, the authors determined serum activity and kinetic constants of angiotensin I-converting enzyme (ACE), parallel to an insertion/deletion (I/D) polymorphism in its gene, in French centenarians and controls 20-70 years of age because this enzyme could have an impact on cardiovascular risk and thus on longevity.
Abstract
We have determined serum activity and kinetic constants of angiotensin I-converting enzyme (ACE), parallel to an insertion/deletion (I/D) polymorphism in its gene, in French centenarians and controls 20-70 years of age because this enzyme could have an impact on cardiovascular risk, and thus on longevity. Both the ACE D allele and ACE D/D genotype were more frequent in centenarians in comparison with controls, without sex-related differences nor significant correlation with a cardiovascular pathology. In centenarians, I/D polymorphism was correlated with circulating ACE activity (D/D genotype, 89.0 +/- 36.8 U/L; I/D genotype, 63.5 +/- 26.0 U/L; and I/I genotype, 55.1 +/- 39.4 U/L). The Michaelis constants for two substrates were identical whatever the genotype and were not different between centenarians and controls, i.e., 0.30 +/- 0.03 mmol/L for furylacryloyl-phenylalanyl-glycyl-glycine and 1.35 +/- 0.05 mmol/L for hippuryl-histidyl-leucine; for the latter, the optimal pH and activating concentration of chloride did not depend on I/D polymorphism. The maximal velocities with both substrates reflected the distribution of serum ACE activity as a function of the genotypes, in centenarians and in controls. In conclusion, plasma ACE activity is subject to a similar genotypic influence in centenarians as in adults 20-70 years of age; however, ACE itself appears to be functionally similar for each genotype. Furthermore, the D allele as well as the higher serum ACE activities associated with the D/D genotype cannot discriminate individuals at high risk for cardiovascular diseases, major causes of mortality before the age of 100 years.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

New Aspects on Angiotensin-Converting Enzyme: from Gene to Disease

TL;DR: ACE gene cloning has confirmed the expression of the enzyme in endothelial cell, in particular as an ecto-enzyme facing the vascular lumen, but not to the same extent with regard to the vascular origin of the cells.
Journal ArticleDOI

A study of French centenarians: are ACE and APOE associated with longevity?

TL;DR: Assessment of the French centenarian cohort allows a new assessment of the hypothesis that certain alleles of two genes, APOE and ACE, are associated with such a complex polyfactorial process as longevity and risk of reporting false positive associations is discussed.
Journal ArticleDOI

Genetic determinants of blood pressure regulation

TL;DR: This review attempts to highlight the genetic basis of hypertension pathogenesis, focusing on the most important existing genetic variations of candidate genes and their potential role in the development of this disease.
Journal ArticleDOI

Alzheimer disease risk and genetic variation in ACE: a meta-analysis.

TL;DR: The I allele of the ACE D/I polymorphism is associated with an increased risk of late-onset Alzheimer disease and further study of the pathogenetic characteristics of this allele is warranted.
Journal ArticleDOI

Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.

TL;DR: Since ACE inhibitors are widely used in hypertension and congestive heart failure, the literature on the relationship of ACEI/D polymorphism with ACE inhibitor response appears that this polymorphism has some moderate impact on the cardiovascular response to ACE inhibitors but there is no consensus as to which allele confers a more pronounced effect.
References
More filters
Journal ArticleDOI

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

TL;DR: The insertion/deletion polymorphism accounted for 47% of the total phenotypic variance of serum ACE, showing that the ACE gene locus is the major locus that determines serum ACE concentration.
Journal ArticleDOI

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction.

TL;DR: It is reported that the DD genotype, which is associated with higher levels of circulating ACE than the ID and II genotypes, is significantly more frequent in patients with myocardial infarction than in controls, especially among subjects with low body-mass index and low plasma levels of ApoB.
Journal Article

Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

TL;DR: A combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism.
Related Papers (5)